Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus.
Sikurová
L
L
Department of Biophysics, Comenius University, Bratislava, Slovakia. sikurova@fmph.uniba.sk
Dérerová
J
J
Kvasnicka
P
P
Waczulíková
I
I
Cársky
J
J
Ulicná
O
O
D016880:Anisotropy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D004910:Erythrocyte Membrane / Q000187:drug effects* / Q000502:physiology; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008560:Membrane Fluidity / Q000187:drug effects*
D006146:Guanidines; C115168:resorcylidene aminoguanidine